After Five Years Of Collaboration, Sanofi & Innate Pharma Expand Oncology Pact With Additional Programs
Innate Pharma SA (NASDAQ:IPHA) and Sanofi SA (NASDAQ:SNY) have expanded their collaboration, with Sanofi licensing a natural killer (NK) cell engager program…